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Abstract
The Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome refers to the congenital absence or
severe hypoplasia of the female genital tract, often described as uterovaginal aplasia which is the
prime feature of the syndrome. It is the second cause of primary amenorrhea after gonadal
dysgenesis and occurs in ~1 in 4500 women. Aetiology of this syndrome remains poorly
understood. Frequent association of other malformations with the MRKH syndrome, involving
kidneys, skeleton and ears, suggests the involvement of major developmental genes such as those
of the HOX family. Indeed mammalian HOX genes are well known for their crucial role during
embryogenesis, particularly in axial skeleton, hindbrain and limb development. More recently, their
involvement in organogenesis has been demonstrated notably during urogenital differentiation.
Although null mutations of HOX genes in animal models do not lead to MRKH-like phenotypes,
dominant mutations in their coding sequences or aberrant expression due to mutated regulatory
regions could well account for it. Sequence analysis of coding regions of HOX candidate genes and
of PBX1, a likely HOX cofactor during Müllerian duct differentiation and kidney morphogenesis,
did not reveal any mutation in patients showing various forms of MRKH syndrome. This tends to
show that HOX genes are not involved in MRKH syndrome. However it does not exclude that
other mechanisms leading to HOX dysfunction may account for the syndrome.
Background
The most common cause of vaginal agenesis is congenital
absence of the uterus and vagina which is also referred to
as Müllerian aplasia, Müllerian agenesis or Mayer-Roki-
tansky-Küster-Hauser (MRKH) syndrome [1]. The fre-
quency of this syndrome is not yet entirely clear, although
reported incidences vary from 1 in 4,000 to 5,000 female
births [1-3]. Affected individuals are clearly phenotypic
females with normally developed ovaries [4,5] and nor-
mal 46, XX karyotype [6,7]. Aetiology of the syndrome is
poorly understood but it is often associated with other
anomalies including renal defects, skeletal abnormalities
and deafness (MURCS association [8]), suggesting the
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involvement of major developmental genes such as HOX
genes [9-12].
The homeobox (HOX) genes belong to a large family of
39 genes organized in four clusters, HOXA, HOXB, HOXC
and HOXD, each on a different chromosome. During org-
anogenesis, the proteins encoded by these genes act
through various and highly complex spatiotemporal com-
binations to trigger positional identity of embryonic cells.
This determines the patterning and segment identity
along the anterior-posterior axis of the skeleton and a vari-
ety of organ systems [13]. For instance, 30 HOX proteins
participate to the elaboration of the spine, 12 for the
digestive tract and 7 for the urogenital tract [14]. More
precisely, Müllerian ducts (the primordia for oviducts,
uterus, cervix and anterior vagina) development seems to
involve relatively few HOX genes in the mouse model.
Indeed, HOXA7 [15], HOXA9 to HOXA13 [16], as well as
HOXD9 to HOXD13 [17], are expressed along the differ-
entiating Müllerian duct. However, alteration of the
female genital tract is only observed in HOXA10, -A11
and -A13 deficient mice (homozygotic inactivation of the
gene): – in HOXA10 -/- mice, the upper part of the uterus
is transformed into oviduct, the uterotubular junction is
abnormal as well as the uterine epithelium and an ante-
rior homeotic transformation of lumbar vertebrae has
occurred [18]; – in HOXA11 -/- mice, the uterus is thinner
and shorter than normal and endometrial glands have not
developed [19]; in HOXA13 -/- mice, the distal Müllerian
duct has not developed [20]. Finally HOXA10 to HOXA13
are also expressed in the developing kidney [21] and are
both required for correct patterning of the skeleton [22].
HOX proteins share in common a highly conserved 60
amino acid DNA binding motif referred to as the homeo-
domain. Proteins containing this domain are regulatory
factors that control expression of target genes [23]. Their
high biological specificity comes from cooperation with
specific cofactors that contribute to modulate DNA bind-
ing specificity. Members of the three amino-acid loop
extension (TALE) class of homeodomain proteins that
comprise the mammalian PBX proteins [24] and the
MEIS-like TALE factors or MEINOX group (mammalian
MEIS and PREP1 proteins) [25] are now considered as
essential cofactors forming heterotrimeric complexes with
HOX proteins that regulate specific target gene transcrip-
tion [26]. Among these cofactors, PBX1 is of great interest
in regards to malformations found in MRKH syndrome: it
Table 1: Forward (F) and reverse (R) primers used for PCR-mediated amplification of genomic DNA of HOXA7 to HOXA13 genes 
exons.
Primer name Gene segment Sequence 5'-3' Product size (bp)
HOXA 7-1-F
HOXA 7-1-R
HOXA-7 exon 1 TTGGTGTAAATCTGGGGGTG
TTAAAACCAGAAAGGCTGCG
637
HOXA 7-2-F
HOXA 7-2-R
HOXA-7 exon 2 GACTAGGCCAGGAGGAAGGT
GGGAGCTGGAGTAGGTGATG
697
HOXA 9-1a-F
HOXA 9-1a-R
HOXA-9 exon 1 (first half) TGCCACCAAGTTGTTACATGA
CAGCGGTTCAGGTTTAATGC
492
HOXA 9-1b-F
HOXA 9-1b-R
HOXA-9 exon 1 (second half) GCAGGTACATGCGCTCCT
AAGGCAGGCTCGAGAGAAAC
356
HOXA 9-2-F
HOXA 9-2-R
HOXA-9 exon 2 TGTGCGTCTTCTGCTCCTAA
CGGACAGTTCTTTCTTTTTCTCTC
343
HOXA 10-1a-F
HOXA 10-1a-R
HOXA-10 exon 1 (first half) CTCCTGGCCCATCAATACAG
GAGACTTTGGGGCATTTGTC
728
HOXA 10-1b-F
HOXA 10-1b-R
HOXA-10 exon 1 (second half) GCGCAGAACATCAAAGAAGA
TCCTTGTGTCTGCCTGTCTG
535
HOXA 10-2-F
HOXA 10-2-R
HOXA-10 exon 2 TGGCCTCGACTTAATCATCC
AGACAGAGGGAGGGGACCAG
378
HOXA 11-1a-F
HOXA 11-1a-R
HOXA-11 exon 1 (first half) CAGCTGCAGTGGAGAATCAT
CTTCTCGGCGCTCTTGTC
562
HOXA 11-1b-F
HOXA 11-1b-R
HOXA-11 exon 1 (second half) TTTTTCGAGACAGCCTACGG
TGCGCTAGATTTCCAACTCC
340
HOXA 11-2-F
HOXA 11-2-R
HOXA-11 exon 2 CTCACCCCATGCCTTTTCT
GTCAAGGGCAAAATCTGCAT
331
HOXA 13-1a-F
HOXA 13-1a-R
HOXA-13 exon 1 (first half) ACTGGGGTCTTCTCCATGC
TGGTGGTAGAAGGCGAACTC
727
HOXA 13-1b-F
HOXA 13-1b-R
HOXA-13 exon 1 (second half) CAACGCCATCAAGTCGTG
AAGACCAGGGCTGGGAATAG
389
HOXA 13-2-F
HOXA 13-2-R
HOXA-13 exon 2 CCGATCCCTGTGTAACTTGC
ATTATCTGGGCAAAGCAACG
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is required for skeletal development and patterning [27],
kidney morphogenesis [28] and especially, its gene inacti-
vation leads to absence of Müllerian structures [29]. Inter-
estingly, PBX1 is expressed in the Müllerian ducts at the
onset of genital tract differentiation whereas it is absent of
Wolffian ducts (the primordia for male inner genital tract)
during the same period and in both sexes [30].
These overall data led us to investigate HOXA7, -A9, -A10,
-A11 and -A13 genes, as well as PBX1, in several MRKH
patients showing a wide range of malformations, from
isolated uterovaginal aplasia to severe MURCS associa-
tion. However null mutations of these genes do not result
in MRKH-like phenotype in the mouse model. This is why
we decided to search for simple or discrete mutations
within their coding and splicing sequences. Indeed, dom-
inant or loss-of-function mutations can impair ability of
the corresponding proteins to fulfil their biological role as
already showed for HOXD13 [31,32].
Case reports
Patient 1
This patient was initially evaluated for a vesicoureteric
reflux that required surgical treatment during which a
small left kidney and a partial uterine agenesis with rudi-
mentary left horn were noticed. This was confirmed latter
by laparoscopy when she was 13 year old. Additional
examination revealed several skeletal abnormalities: coxa
valga, unequal leg length, flexus adductus as well as L4
vertebra and sacrum malformation. At 18 year of age,
laparoscopic-assisted Vechietti procedure [33] was per-
formed. Finally her karyotype was normal.
Patient 2
This 25-year-old white woman was initially evaluated for
proteinuria. Examination revealed a right single pelvic
kidney and uterovaginal agenesis. She had normal sexual
secondary development. Kidney biopsy showed focal and
segmental hyalinosis. Spine radiograms were normal. Her
karyotype was normal. At 26, she was treated by sigmoid
colpoplasty [34]. During surgery, uterovaginal agenesis
was confirmed with small rudimentary uterine horns.
Patient 3
This 20-year-old white woman was evaluated for primary
amenorrhea. She had normal secondary sexual develop-
ment. There was no cyclic abdominal pain. Family history
was unremarkable. The MRKH diagnosis was confirmed
by laparoscopy. Absence of right ovary and fallopian tube
was noticed during surgery. However, ultrasound exami-
nation showed normal kidneys.
Patients 4 to 6
These patients are three Turkish sisters already described
[35] (patients III2, III3, III5 of pedigree). Interestingly, in
this family, the fourth sister (III4) was not affected but
two paternal aunts (II6 and II7), among 8 siblings, were
sterile and were told they had no uterus. This three sisters
case corresponds to typical MRKH syndrome with primary
amenorrhea, normal sexual secondary development and
absence of the vagina at physical evaluation. The Mülle-
rian agenesis was confirmed by ultrasound examination
and magnetic resonance imaging of pelvis. Their karyo-
types were normal. Intravenous pyelogram and spine
radiograms were normal in each case.
Table 2: Forward (F) and reverse (R) primers used for PCR-mediated amplification of genomic DNA of PBX1 gene exons.
Primer name Gene segment Sequence 5'-3' Product size (bp)
PBX1-1-F
PBX1-1-R
PBX1 exon 1 TTTCCCCCTTCCCTGTTTAT
GTGATTCGGTTCCCATTGTT
334
PBX1-2-F
PBX1-2-R
PBX1 exon 2 CAAATGTTTTCACCCTGTGC
TTTGTGACTGCTGGTTAAGTGA
223
PBX1-3-F
PBX1-3-R
PBX1 exon 3 TGGCAGCTTATGTAGCCAAA
GTTGTGCTTCCTCCACCCT
404
PBX1-4-F
PBX1-4-R
PBX1 exon 4 GCCCACGTGGCCTAATGTCATA
TGGGGTGAAACTAGAGCCTG
372
PBX1-5-F
PBX1-5-R
PBX1 exon 5 TGCTCCAAATTCACCTTTTG
AAGACCTCTAAGAGCCTGCC
331
PBX1-6-F
PBX1-6-R
PBX1 exon 6 TTCACCTCTCCCATAAAGCC
CCCAATGTAGGAACAGCCAG
324
PBX1-7-F
PBX1-7-R
PBX1 exon 7 GGTTGCTTTGCATGTCATTC
TCTTGATTTTGGTTCGGTCG
354
PBX1-8-F
PBX1-8-R
PBX1 exon 8 TCTGCCTCCCTTTTCCTACA
GATGGCATGACCGATACAGA
304
PBX1-9-F
PBX1-9-R
PBX1 exon 9 AAACAGCCACCCAATCTCAG
TGTTTGCTGATTGCTTCGAC
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PCR Amplification and sequencing
Total genomic DNA was prepared from peripheral blood
leukocytes according to standard procedures [36]. Local
ethical review and consenting procedures were followed.
PCR primers were designed to amplify HOXA7, HOXA9,
HOXA10, HOXA11, HOXA13 (Table 1) and PBX1 coding
exons (Table 2). PCR reactions were carried out in 25 µl
containing 500 ng genomic DNA, PCR buffer (50 mM
KCl, 10 mM Tris HCl, pH 9.0), 1.5 mM MgCl2, 0.2 mM
dNTP, 10 pmol of each primer, and 2.5 U Taq polymerase
(Promega). PCR amplification was carried out using the
"touchdown" methodology, with an initial denaturation
step at 96°C for 3 min. followed by 19 touchdown cycles
of 45 s at 96°C, 45 s at an initial melting temperature
(Tm) of 69°C (with a 1°C Tm decrease by each cycle), and
60 s at 72°C. Amplification was then achieved by 11
cycles of 45 s at 96°C, 45 s at 50°C, and 60 s at 72°C, with
a final extension at 72°C for 10 min. For the N-terminal
exon 1 of HOXA13 gene, DMSO (5%) was added to PCR
mix. 6 µl PCR product previously controlled on a 2% aga-
rose gel, was incubated with 5 units of exonuclease I
(Amersham Biosciences) and 1 unit of shrimp alkaline
phosphatase (Amersham Pharmacia) in order to digest
remaining primers and to inactivate unincorporated
nucleotides. The enzymatic reaction was stopped by a step
at 90°C for 15 min. Bidirectional sequencing of the PCR
products was achieved using the BigDye Terminator
chemistry (PE Applied Biosystems) and each of exon-spe-
cific primers. Electrophoresis and analysis were performed
on an ABI Prism 377 (PE Applied Biosystems). Sequences
were analyzed and compared with sequences downloaded
from GenBank by DNAStar software (DNAStar).
Results and discussion
The pattern of malformations observed in MRKH patients
was, in our hypothesis, in favour of a HOX gene dysfunc-
tion. However no mutation as well as length/nucleotide
polymorphism was found in the coding sequences of
HOXA7 to -A13 genes of the patients we investigated. This
probably refutes the hypothesis of dominant or loss-of-
function mutations like those found in HOXD13 [31,32]
and seems to show that quality of the corresponding pro-
teins, if correctly expressed, can not be incriminated.
Interestingly, reduced quantity of HOXA proteins (hap-
loinsufficiency of the entire HOXA gene cluster) does not
cause any of the major malformations observed in MRKH
syndrome but leads to other congenital anomalies [37].
Nevertheless, other mechanisms can be suggested, such as
upstream misregulation of some genes of the HOXA clus-
ter, post-transcriptional anomalies, HOX partners' defi-
ciency or defaults in HOX-target genes, all potentially
leading to HOX-like phenotypes.
HOX genes clusters undergo very complex transcriptional
controls during development, including general switch
such as retinoic acid induction [38], FGFs [39,40] or Wnt
[41] signalling, self-regulatory loops, specific induction or
repression of HOX genes within the same cluster [42-44],
as well as post-transcriptional regulations [45,46].
Although large-scale developmental signals deficiency
would probably not account for restricted and non lethal
malformations such as those observed for the MRKH syn-
drome, HOX misregulation due to mutations/deletions
outside the coding regions could do it as already described
in the HOXD gene cluster [47] and in HOXA13 gene pro-
moter [48]. Some few regulatory regions have been char-
acterized in the HOXA gene cluster among which, the so-
called HCR (Human Control Region) [49] lying next to
HOXA7, a gene somehow involved in Müllerian differen-
tiation [15]. This 1.1 kb DNA sequence, as well as its con-
served mouse equivalent, has been shown to set the
anterior boundary of HOXA7 expression [49] and there-
fore putative other HOXA genes of the same cluster.
Southern-blot experiments aiming at detecting length pol-
ymorphism such as deletion or duplication in the [HCR-
HOXA7] area did not reveal any major genetic event in
any of the patients investigated (results not shown). This
however does not imply that other regulatory regions still
uncharacterized in the HOXA cluster, may not be involved
in the MRKH syndrome.
Post-transcriptional regulations also take place in the
overall mechanisms of HOX gene expression and partici-
pate to the elaboration of the code referred to as "combi-
natorial HOX code". In this way, normal and alternative
splicing of HOX pre-messengers [45,46] often results in
two isoforms that putatively can antagonize each other
[50,51]. In our experimental approach, we designed PCR/
sequencing primers so that we were able to verify the cor-
rect splicing acceptor and donor sites sequences of all
exons for every gene investigated (including PBX1). No
mutation was found in these sites.
PBX1 is one of the HOX genes' partners the most likely to
be involved in the MRKH syndrome. Heterozygotic (+/-)
inactivation of this gene does not provoke any congenital
malformation in the mouse model whereas homozygotic
(-/-) mice embryos die before birth due to multiple and
severe malformations [27]. Therefore haploinsufficiency
will probably not cause MRKH phenotype although
mono-allelic mutations in a coding region of the gene
may well lead to a dominant and deleterious effect such as
titrating of HOX proteins clustered in non functional
complexes. We carefully sequenced the overall exons of
PBX1 in every patient and did not observe any mutation.
Conclusion
Investigation of candidate genes in biomedical research
has often been unsuccessful unless target genes were obvi-
ous (for instance, see [52-54]). HOX genes, which playJournal of Negative Results in BioMedicine 2006, 5:4 http://www.jnrbm.com/content/5/1/4
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numerous roles during development, were good candi-
dates for MRKH syndrome, based on deduction from their
expression pattern during mouse development and from
the phenotype of mice with a targeted disruption or over-
expression of a specific HOX gene. Similar hypotheses
were assumed for others congenital malformations or syn-
dromes and revealed the involvement of these genes
[55,56]. We based the present work on the investigation
of MRKH patients showing various malformations associ-
ated with uterovaginal aplasia. This choice was based on
the probable multigenic origins of the syndrome, assum-
ing that at least one case would lead to evidence mutation
of either a coding sequence of a HOX gene or part of the
HOXA cluster (HOXA7 to -A13). Amongst the various
MRKH cases analysed, we did not find any mutation in
the coding sequences or in the [HCR-HOXA7] region.
However, we did not sequence the whole HOXA cluster in
every patient as this would have been a tremendous work
but rather targeted genomic regions (coding sequences,
splicing sites, regulatory sequences). Our negative results
therefore do not mean that HOX genes are not involved in
the syndrome. Additional investigation is necessary to set-
tle or not the HOX hypothesis. This requires performing
genetic linkage analysis of familial cases and whole-
genome scan to seek for candidate chromosomal loci.
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